Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions.

Cortical superficial siderosis describes a distinct pattern of blood-breakdown product deposition limited to cortical sulci over the convexities of the cerebral hemispheres, sparing the brainstem, cerebellum and spinal cord. Although cortical superficial siderosis has many possible causes, it is emerging as a key feature of cerebral amyloid angiopathy, a common and important age-related cerebral small vessel disorder leading to intracerebral haemorrhage and dementia. In cerebral amyloid angiopathy cohorts, cortical superficial siderosis is associated with characteristic clinical symptoms, including transient focal neurological episodes; preliminary data also suggest an association with a high risk of future intracerebral haemorrhage, with potential implications for antithrombotic treatment decisions. Thus, cortical superficial siderosis is of relevance to neurologists working in neurovascular, memory and epilepsy clinics, and neurovascular emergency services, emphasizing the need for appropriate blood-sensitive magnetic resonance sequences to be routinely acquired in these clinical settings. In this review we focus on recent developments in neuroimaging and detection, aetiology, prevalence, pathophysiology and clinical significance of cortical superficial siderosis, with a particular emphasis on cerebral amyloid angiopathy. We also highlight important areas for future investigation and propose standards for evaluating cortical superficial siderosis in research studies.

[1]  Eric E. Smith,et al.  Impaired visual evoked flow velocity response in cerebral amyloid angiopathy , 2008, Neurology.

[2]  R. Hamill Report Of A Case Of Melanosis Of The Brain, Cord And Meninges , 1908 .

[3]  H. Stefan,et al.  Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: A study in patients with cavernous haemangiomas associated with symptomatic epilepsy , 2007, Seizure.

[4]  C. Enzinger,et al.  Clinical Presentation, Etiology, and Long-Term Prognosis in Patients With Nontraumatic Convexal Subarachnoid Hemorrhage , 2011, Stroke.

[5]  K. Asaoka,et al.  A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign? , 2007, Surgical neurology.

[6]  M. L. Lauzon,et al.  Susceptibility-Weighted Imaging is More Reliable Than T2*-Weighted Gradient-Recalled Echo MRI for Detecting Microbleeds , 2013, Stroke.

[7]  Eric E. Smith,et al.  Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy , 2010, Neurology.

[8]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[9]  U Dirnagl,et al.  Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? , 2000, Journal of neurosurgery.

[10]  D. Werring,et al.  Outcome markers for clinical trials in cerebral amyloid angiopathy , 2001, The Lancet Neurology.

[11]  S. Kumar,et al.  Atraumatic convexal subarachnoid hemorrhage , 2010, Neurology.

[12]  生駒 一憲,et al.  4.Susceptibility Weighted Imaging (SWI)法によるびまん性軸索損傷の評価の検討(地方会,第13回 日本リハビリテーション医学会 北海道地方会) , 2006 .

[13]  R. Paterson,et al.  Recurrent Stereotyped Episodes in Cerebral Amyloid Angiopathy: Response to Migraine Prophylaxis in Two Patients , 2013, Cerebrovascular Diseases Extra.

[14]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[15]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[16]  Anand Viswanathan,et al.  Topography of dilated perivascular spaces in subjects from a memory clinic cohort , 2013, Neurology.

[17]  J. Baron,et al.  Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy , 2013, Neurology.

[18]  D. Werring,et al.  Cortical superficial siderosis , 2015, Neurology.

[19]  T. Mendel,et al.  Cortical superficial siderosis, APOE genotype, and hemorrhage risk in cerebral amyloid angiopathy , 2015, Neurology.

[20]  J. Baron,et al.  Spectrum of Transient Focal Neurological Episodes in Cerebral Amyloid Angiopathy: Multicentre Magnetic Resonance Imaging Cohort Study and Meta-Analysis , 2012, Stroke.

[21]  D. Leys,et al.  Superficial Siderosis of the Central Nervous System: A Post-Mortem 7.0-Tesla Magnetic Resonance Imaging Study with Neuropathological Correlates , 2013, Cerebrovascular Diseases.

[22]  M. Wiesmann,et al.  Subarachnoid Hemosiderosis and Superficial Cortical Hemosiderosis in Cerebral Amyloid Angiopathy , 2008, American Journal of Neuroradiology.

[23]  J. Baron,et al.  Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy , 2013, Neurology.

[24]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[25]  A. Koeppen,et al.  The pathogenesis of superficial siderosis of the central nervous system , 1993, Annals of neurology.

[26]  J S Thornton,et al.  Choice of echo time on GRE T2*-weighted MRI influences the classification of brain microbleeds. , 2010, Clinical radiology.

[27]  Clifford R. Jack,et al.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.

[28]  M. Maas,et al.  Subarachnoid Extension of Primary Intracerebral Hemorrhage is Associated With Poor Outcomes , 2013, Stroke.

[29]  M. Dichgans,et al.  Superficial siderosis is a warning sign for future intracranial hemorrhage , 2012, Journal of Neurology.

[30]  P Aspelin,et al.  SWI or T2*: Which MRI Sequence to Use in the Detection of Cerebral Microbleeds? The Karolinska Imaging Dementia Study , 2015, American Journal of Neuroradiology.

[31]  R. Porcher,et al.  Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors , 2010, Stroke.

[32]  D. Werring,et al.  Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  M. Dichgans,et al.  Prevalence of cortical superficial siderosis in patients with cognitive impairment , 2014, Journal of Neurology.

[34]  Eric E. Smith,et al.  Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage , 2004, Stroke.

[35]  Nick C Fox,et al.  Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis , 2012, The Lancet Neurology.

[36]  J. Honnorat,et al.  Transient Neurologic Symptoms Related to Cerebral Amyloid Angiopathy: Usefulness of T2*-Weighted Imaging , 2005, Cerebrovascular Diseases.

[37]  D. Field,et al.  Aura attacks from acute convexity subarachnoid haemorrhage not due to cerebral amyloid angiopathy , 2011, Cephalalgia : an international journal of headache.

[38]  J. Baron,et al.  Transient Focal Neurological Episodes, Cerebral Amyloid Angiopathy, and Intracerebral Hemorrhage Risk: Looking beyond TIAs , 2013, International journal of stroke : official journal of the International Stroke Society.

[39]  H. Feldman,et al.  Clinical phenotypes of Cerebral Amyloid Angiopathy , 2007, Journal of the Neurological Sciences.

[40]  Keith A. Johnson,et al.  Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy , 2012, Neurology.

[41]  R. Porcher,et al.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. , 2007, Brain : a journal of neurology.

[42]  H. Feldman,et al.  Superficial Siderosis: A Potential Diagnostic Marker of Cerebral Amyloid Angiopathy in Alzheimer Disease , 2008, Stroke.

[43]  S. Greenberg,et al.  Small vessels, big problems. , 2006, The New England journal of medicine.

[44]  D. Werring,et al.  Amyloid “spells” trouble , 2012, The Lancet.

[45]  S. Atlas,et al.  Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. , 1988, Radiology.

[46]  Leon Poller,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[47]  P. Kirchhof,et al.  Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. , 2008, Academic radiology.

[48]  Ana Catarina Fonseca,et al.  Nontraumatic convexity subarachnoid hemorrhage: different etiologies and outcomes. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[49]  T. Miyatake,et al.  Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly , 1993, Journal of Neurological Sciences.

[50]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[51]  D. Prashantha,et al.  Localized convexity subarachnoid haemorrhage – a sign of early cerebral venous sinus thrombosis , 2010, European journal of neurology.

[52]  A. Koeppen,et al.  The pathology of superficial siderosis of the central nervous system , 2008, Acta Neuropathologica.

[53]  D. Smith,et al.  Cerebral amyloid angiopathy presenting as transient ischemic attacks. Case report. , 1985, Journal of neurosurgery.

[54]  K. Hinokuma,et al.  Subcortical hematoma caused by cerebral amyloid angiopathy: Does the first evidence of hemorrhage occur in the subarachnoid space? , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[55]  F. Andermann,et al.  Seizure Outcome after Resection of Cavernous Malformations Is Better When Surrounding Hemosiderin‐stained Brain Also Is Removed , 2006, Epilepsia.

[56]  B. Iung,et al.  Infective Endocarditis with Symptomatic Cerebral Complications: Contribution of Cerebral Magnetic Resonance Imaging , 2013, Cerebrovascular Diseases.

[57]  H. Mehdorn,et al.  Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage , 2004, Journal of Zhejiang University. Science.

[58]  V. Larrue,et al.  Isolated Acute Nontraumatic Cortical Subarachnoid Hemorrhage , 2010, American Journal of Neuroradiology.

[59]  Richard Frayne,et al.  Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy , 2013, Neurology.

[60]  W. M. van der Flier,et al.  Prevalence of cortical superficial siderosis in a memory clinic population , 2014, Neurology.

[61]  M. Frosch,et al.  Cerebral amyloid angiopathy with and without hemorrhage , 2015, Neurology.

[62]  Koeppen Ah Superficial siderosis of the central nervous system. , 1971 .

[63]  K. Hinokuma,et al.  The hemorrhage caused by sporadic‐type cerebral amyloid angiopathy occurs primarily in the cerebral sulci , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

[64]  Z. Wu,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 , 2008, American Journal of Neuroradiology.

[65]  P. Labauge,et al.  [Focal convexal subarachnoid hemorrhage: clinical presentation, imaging patterns and etiologic findings in 23 patients]. , 2013, Revue neurologique.

[66]  A. Koeppen,et al.  SUPERFICIAL SIDEROSIS OF THE CENTRAL NERVOUS SYSTEM A HISTOLOGICAL, HISTOCHEMICAL AND CHEMICAL STUDY , 1971, Journal of neuropathology and experimental neurology.

[67]  Aad van der Lugt,et al.  Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. , 2008, Radiology.

[68]  S. Finklestein,et al.  Petechial hemorrhages accompanying lobar hemorrhage , 1996, Neurology.

[69]  M. Yamada,et al.  Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. , 1997, Journal of medical and dental sciences.

[70]  A. Singhal,et al.  Primary angiitis of the CNS , 2011, The Lancet Neurology.

[71]  Young T. Hong,et al.  Diagnostic Utility of Amyloid PET in Cerebral Amyloid Angiopathy-Related Symptomatic Intracerebral Hemorrhage , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  A. Ducros,et al.  Reversible cerebral vasoconstriction syndrome , 2009, Practical Neurology.

[73]  C. Brayne,et al.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review , 2009, BMC neurology.

[74]  Anand Viswanathan,et al.  Cerebral amyloid angiopathy in the elderly , 2011, Annals of neurology.

[75]  Aad van der Lugt,et al.  O3-04-07 Prevalence and risk factors of cerebral microbleeds in the Rotterdam scan study , 2006, Alzheimer's & Dementia.

[76]  S. Finklestein,et al.  The clinical spectrum of cerebral amyloid angiopathy , 1993, Neurology.

[77]  Y. Béjot,et al.  Transient Ischaemic Attack Mimics Revealing Focal Subarachnoid Haemorrhage , 2010, Cerebrovascular Diseases.

[78]  J. Stevens,et al.  REVIEW ARTICLESuperficial siderosis of the central nervous system , 1995 .

[79]  M. Wiesmann,et al.  Cortical vein thrombosis: the diagnostic value of different imaging modalities , 2010, Neuroradiology.

[80]  C. Sudlow,et al.  APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[81]  J. Mas,et al.  Hémorragies sous-arachnoïdiennes corticales focales : présentation clinique, radiologique et diagnostic étiologique dans une série de 23 patients , 2013 .

[82]  Brad J Kolls,et al.  A PHASE 2 MULTIPLE ASCENDING DOSE TRIAL OF BAPINEUZUMAB IN MILD TO MODERATE ALZHEIMER DISEASE , 2010, Neurology.

[83]  M. Pangalos,et al.  Multimodal Magnetic Resonance Imaging for Assessing Evolution of Ischemic Penumbra: A Key Translational Medicine Strategy to Manage the Risk of Developing Novel Therapies for Acute Ischemic Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[84]  M. van Buchem,et al.  Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy , 2010, Neurology.

[85]  Eric E. Smith,et al.  Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.

[86]  J. Baron,et al.  White matter perivascular spaces , 2014, Neurology.

[87]  M. van Buchem,et al.  Descriptive Analysis of the Boston Criteria Applied to a Dutch-Type Cerebral Amyloid Angiopathy Population , 2009, Stroke.

[88]  M. Woodward,et al.  Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial , 2010, Stroke.

[89]  M. Oehmichen,et al.  Timing of cortical contusion , 2005, Zeitschrift für Rechtsmedizin.

[90]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[91]  Keith A. Johnson,et al.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study , 2013, Annals of neurology.

[92]  Apixaban versus Warfarin in Patients with Atrial Fibrillation , 2012 .

[93]  A. Hofman,et al.  Superficial siderosis in the general population , 2009, Neurology.

[94]  Frederik Barkhof,et al.  Clinical Relevance of Improved Microbleed Detection by Susceptibility-Weighted Magnetic Resonance Imaging , 2011, Stroke.

[95]  Eric E. Smith,et al.  MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength , 2008, American Journal of Neuroradiology.

[96]  AshanKhurram,et al.  Clinical Associations and Causes of Convexity Subarachnoid Hemorrhage , 2014 .

[97]  V. Di Lazzaro,et al.  Recurrent Subarachnoid Bleeding and Superficial Siderosis in a Patient with Histopathologically Proven Cerebral Amyloid Angiopathy , 2011, Case Reports in Neurology.

[98]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[99]  F. Barkhof,et al.  Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. , 2012, Archives of neurology.

[100]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[101]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[102]  S. Leurgans,et al.  Cerebral amyloid angiopathy pathology and cognitive domains in older persons , 2011, Annals of neurology.

[103]  S. Greenberg,et al.  Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy , 2014, Neurology.

[104]  D. Piepgras,et al.  Superficial siderosis , 2006, Neurology.

[105]  Sandeep Mittal,et al.  Identification of calcification with MRI using susceptibility‐weighted imaging: A case study , 2009, Journal of magnetic resonance imaging : JMRI.

[106]  J. Dreier The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease , 2011, Nature Medicine.

[107]  J. Baron,et al.  Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. , 2011, Brain : a journal of neurology.

[108]  P. Finelli Cerebral Amyloid Angiopathy as Cause of Convexity SAH in Elderly , 2010, The neurologist.

[109]  V. Larrue,et al.  Cortical subarachnoid haemorrhage in the elderly: a recurrent event probably related to cerebral amyloid angiopathy , 2011, European journal of neurology.